Caprini scores and routine anticoagulation are promoted to reduce venous thromboembolism (VTE) risk in a meta-analysis published recently in *Annals of Surgery*.^[@R1]^ However, factual errors beg disclosure.

Pannucci et al.^[@R1]^ reported a 2.45% (149/6,085) overall VTE risk for patients who did not receive chemoprophylaxis but did not report the 4.37% (380/8,691) risk for patients who did receive chemoprophylaxis (*P* \< 0.0001). According to Figure 4, the VTE rate for patients with Caprini scores of 5 and 6 was significantly greater for anticoagulated patients (3.54% versus 1.85%; *P* \< 0.001).^[@R1]^ For patients with Caprini scores of 7 and 8, the VTE risks were 5.37% for patients receiving chemoprophylaxis versus 4.02% for untreated patients, not significantly reduced for anticoagulated patients, as claimed.^[@R1]^ Among patients with Caprini scores ≥ 5, the VTE risk was significantly greater (*P* \< 0.001) for anticoagulated patients (comparisons performed using a chi-square test^[@R2]^).

One of the studies included in the meta-analysis, by Jeong et al.,^[@R3]^ reported 19 VTEs among 574 plastic surgery patients who received chemoprophylaxis and only 5 VTEs among 1,024 patients who did not receive chemoprophylaxis (*P* \< 0.00001). These numbers are much different from those reported in the meta-analysis (5/238 and 3/301, respectively).^[@R1]^ Correcting this error reduces the *P* value (already \< 0.0001) favoring the untreated patients to essentially zero.^[@R2]^

Pannucci et al.^[@R1]^ reported that anticoagulated plastic surgery inpatients with Caprini scores of 7 to 8 or \> 8 have a significant VTE risk reduction. However, the referenced study found that these differences were not significant (*P* = 0.230 and 0.182, respectively).^[@R4]^ Moreover, a subsequent review by the same lead author found no significant difference in VTE risk (*P* = 0.08) for plastic surgery inpatients when compared by Caprini scores but a higher risk of bleeding (*P* = 0.02) in anticoagulated patients.^[@R5]^ The bleeding risk was also significantly increased (*P* = 0.006) in the recent meta-analysis,^[@R1]^ contradicting a previous study that found no significant difference.^[@R6]^

The title references risk in surgical patients, but the authors included 1,176 nonsurgical patients.^[@R7],[@R8]^ The authors report poor comparability scores.^[@R1]^ A bewildering number of confounding variables undermines the comparisons. These include a cancer diagnosis, having surgery, the type of surgery, anesthesia, the method of VTE diagnosis, follow-up interval, sequential compression devices, whether upper-extremity thromboses and superficial thromboses are included, and the method of evaluating the 40 parameters that make up a Caprini score. Retrospectively evaluating Caprini scores based on chart reviews or insurance billing information is unreliable.^[@R9]^ For example, Obi et al.^[@R7]^ recorded only 1 patient with a history of varicose veins among 4,844 patients admitted to an intensive care unit. Pannucci et al.^[@R1]^ did not report the results of their funnel plot analysis to evaluate publication bias. The selected articles share a bias for chemoprophylaxis. One study grouped patients according to "appropriate" and "inappropriate" prophylaxis and called failure to administer chemoprophylaxis "malpractice."^[@R10]^

The false-positive rate for individual risk stratification is consistently 97% and almost half of the affected patients are missed using Caprini scores ≥ 7 as a cutoff.^[@R11]^ This method can hardly be considered "precision medicine" or capable of predicting VTE risk, as claimed.^[@R1]^ In evaluating the American Association for Accreditation of Ambulatory Surgery Facilities data for 354,969 abdominoplasties, Keyes (Personal communication, February 7, 2017) finds Caprini scores unhelpful because 135 (67.5%) of the 200 VTEs occurred in patients with Caprini scores \< 5. The evidence-based surgeon will make treatment choices based on the facts, not the conventional wisdom.

*Facts are stubborn things*. ---John Adams.
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